TY - JOUR
T1 - Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation
T2 - A pilot control clinical study
AU - Abodonya, Ahmed M.
AU - Kamal Abdelbasset, Walid
AU - Awad, Elsayed A.
AU - Elalfy, Ibrahim E.
AU - Salem, Hosni A.
AU - Elsayed, Shereen H.
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/4/2
Y1 - 2021/4/2
N2 - Background.To the best of our knowledge, no studies have evaluated the effects of inspiratory muscle training (IMT) on recovered COVID-19 patients after weaning from mechanical ventilation. Therefore, this study assessed the efficacy of IMT on recovered COVID-19 patients following mechanical ventilation.Methods.Forty-Two recovered COVID-19 patients (33 men and 9 women) weaned from mechanical ventilation with a mean age of 48.05 ± 8.85 years were enrolled in this pilot control clinical study. Twenty-one patients were equipped to 2-week IMT (IMT group) and 21 matched peers were recruited as a control (control group). Forced vital capacity (FVC%), forced expiratory volume in 1 second (FEV1%), dyspnea severity index (DSI), quality of life (QOL), and six-minute walk test (6-MWT) were assessed initially before starting the study intervention and immediately after intervention.Results.Significant interaction effects were observed in the IMT when compared to control group, FVC% (F = 5.31, P = .041, ηP2= 0.13), FEV1% (F = 4.91, P = .043, ηP2= 0.12), DSI (F = 4.56, P = .032, ηP2= 0.15), QOL (F = 6.14, P = .021, ηP2= 0.17), and 6-MWT (F = 9.34, P = .028, ηP2= 0.16). Within-group analysis showed a significant improvement in the IMT group (FVC%, P = .047, FEV1%, P = .039, DSI, P = .001, QOL, P < .001, and 6-MWT, P < .001), whereas the control group displayed nonsignificant changes (P > .05).Conclusions.A 2-week IMT improves pulmonary functions, dyspnea, functional performance, and QOL in recovered intensive care unit (ICU) COVID-19 patients after consecutive weaning from mechanical ventilation. IMT program should be encouraged in the COVID-19 management protocol, specifically with ICU patients.
AB - Background.To the best of our knowledge, no studies have evaluated the effects of inspiratory muscle training (IMT) on recovered COVID-19 patients after weaning from mechanical ventilation. Therefore, this study assessed the efficacy of IMT on recovered COVID-19 patients following mechanical ventilation.Methods.Forty-Two recovered COVID-19 patients (33 men and 9 women) weaned from mechanical ventilation with a mean age of 48.05 ± 8.85 years were enrolled in this pilot control clinical study. Twenty-one patients were equipped to 2-week IMT (IMT group) and 21 matched peers were recruited as a control (control group). Forced vital capacity (FVC%), forced expiratory volume in 1 second (FEV1%), dyspnea severity index (DSI), quality of life (QOL), and six-minute walk test (6-MWT) were assessed initially before starting the study intervention and immediately after intervention.Results.Significant interaction effects were observed in the IMT when compared to control group, FVC% (F = 5.31, P = .041, ηP2= 0.13), FEV1% (F = 4.91, P = .043, ηP2= 0.12), DSI (F = 4.56, P = .032, ηP2= 0.15), QOL (F = 6.14, P = .021, ηP2= 0.17), and 6-MWT (F = 9.34, P = .028, ηP2= 0.16). Within-group analysis showed a significant improvement in the IMT group (FVC%, P = .047, FEV1%, P = .039, DSI, P = .001, QOL, P < .001, and 6-MWT, P < .001), whereas the control group displayed nonsignificant changes (P > .05).Conclusions.A 2-week IMT improves pulmonary functions, dyspnea, functional performance, and QOL in recovered intensive care unit (ICU) COVID-19 patients after consecutive weaning from mechanical ventilation. IMT program should be encouraged in the COVID-19 management protocol, specifically with ICU patients.
KW - COVID-19
KW - dyspnea
KW - functional capacity
KW - inspiratory muscle training
KW - mechanical ventilation
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85103745404&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000025339
DO - 10.1097/MD.0000000000025339
M3 - Article
C2 - 33787632
AN - SCOPUS:85103745404
SN - 0025-7974
VL - 100
SP - E25339
JO - Medicine (United States)
JF - Medicine (United States)
IS - 13
ER -